TBK1 exosite inhibitor (Exo Therapeutics)

N/A

Report date: 2025/06/11 10:43:33
NME

Base Information

Drug NameTBK1 exosite inhibitor (Exo Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase TBK1 inhibitors
TargetsSerine/threonine-protein kinase TBK1
Therapy Area/IndicationsAutoimmune DiseasesScleroderma, SystemicLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesExo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesScleroderma, SystemicLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A